CoChat

High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1

Open access
Steins, Anne, van Mackelenbergh, Madelaine G, van der Zalm, Amber P, Klaassen, Remy, Serrels, Bryan, Goris, Sandrine G, Kocher, Hemant M, Waasdorp, Cynthia, de Jong, Joan H, Tekin, Cansu, Besselink, Marc G, Busch, Olivier R, van de Vijver, Marc J, Verheij, Joanne, Dijk, Frederike, van Tienhoven, Geertjan, Wilmink, Johanna W, Medema, Jan Paul, van Laarhoven, Hanneke WM, Bijlsma, Maarten F · 2020 · EMBO reports
Cited by 39

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Pancreatic ductal adenocarcinoma ( PDAC ) is characterized by an abundance of stroma. Multiple molecular classification efforts have identified a mesenchymal tumor subtype that is consistently characterized by high‐grade growth and poor clinical outcome. The relation between PDAC stroma and tumor subtypes is still unclear. Here, we aimed to identify how PDAC cells instruct the main cellular component of stroma, the pancreatic stellate cells ( PSC s). We found in primary tissue that high‐grade PDAC had reduced collagen deposition compared to low‐grade PDAC . Xenografts and organotypic co‐cultures established from mesenchymal‐like PDAC cells featured reduced collagen and activated PSC content. Medium transfer experiments using a large set of PDAC cell lines revealed that mesenchymal‐like PDAC cells consistently downregulated ACTA 2 and COL 1A1 expression in PSC s and reduced proliferation. We identified colony‐stimulating factor 1 as the mesenchymal PDAC ‐derived ligand that deactivates PSC s, and inhibition of its receptor CSF 1R was able to counteract this effect. In conclusion, high‐grade PDAC features stroma that is low in collagen and activated PSC content, and targeting CSF 1R offers direct options to maintain a tumor‐restricting microenvironment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embr.201948780

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 39

Metadata

Authors
Steins, A., van Mackelenbergh, M. G., van der Zalm, A. P., Klaassen, R., Serrels, B., Goris, S. G., Kocher, H. M., Waasdorp, C., de Jong, J. H., Tekin, C., Besselink, M. G., Busch, O. R., van de Vijver, M. J., Verheij, J., Dijk, F., van Tienhoven, G., Wilmink, J. W., Medema, J. P., van Laarhoven, H. W., & Bijlsma, M. F.
Venue
EMBO reports
Published
2020-03-16
Volume
21
Issue
5
Pages
e48780-e48780
ISSN
  • 1469-221X (ISSN-L)
  • 1469-3178
OpenAlex
W3011537144
Cited by
39
References
13
FWCI
2.57
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1. https://app.cochat.ai/papers/10.15252/embr.201948780
The paper
Steins, A., van Mackelenbergh, M. G., van der Zalm, A. P., Klaassen, R., Serrels, B., Goris, S. G., Kocher, H. M., Waasdorp, C., de Jong, J. H., Tekin, C., Besselink, M. G., Busch, O. R., van de Vijver, M. J., Verheij, J., Dijk, F., van Tienhoven, G., Wilmink, J. W., Medema, J. P., van Laarhoven, H. W., & Bijlsma, M. F. (2020). High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1. EMBO reports. https://doi.org/10.15252/embr.201948780

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.